Daniel Szydlo Selected Research

norethindrone enanthate

1/2019

Risk of HIV-1 acquisition among South African women using a variety of contraceptive methods in a prospective study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Daniel Szydlo Research Topics

Disease

3	COVID-19 07/2023 - 10/2021
2	Breakthrough Infections 01/2022 - 10/2021
2	Infections 01/2022 - 01/2019
1	HIV Seropositivity 01/2024
1	Sexually Transmitted Diseases (Sexually Transmitted Disease) 01/2019
1	Out-of-Hospital Cardiac Arrest 09/2012
1	Hepatocellular Carcinoma (Hepatoma) 02/2012

Drug/Important Bio-Agent (IBA)

3	VaccinesIBA 07/2023 - 10/2021
3	BNT162 VaccineIBA 07/2023 - 10/2021
3	Ad26COVS1IBA 07/2023 - 10/2021
3	2019-nCoV Vaccine mRNA-1273IBA 07/2023 - 10/2021
2	COVID-19 VaccinesIBA 01/2022 - 10/2021
1	RNA (Ribonucleic Acid)IBA 01/2024
1	NVX-CoV2373 adjuvated lipid nanoparticleIBA 07/2023
1	Neutralizing AntibodiesIBA 07/2023
1	Proteins (Proteins, Gene)FDA Link 07/2023
1	Messenger RNA (mRNA)IBA 07/2023
1	Dihydrotachysterol (AT 10)IBA 01/2022
1	N,N-dimethyl-4-anisidine (DMPA)IBA 01/2019
1	norethindrone enanthateIBA 01/2019
1	Bortezomib (Velcade)FDA Link 02/2012

Therapy/Procedure

1	Contraception (Birth Control) 01/2019
1	Cardiopulmonary Resuscitation (CPR) 09/2012
1	Airway Management 09/2012